BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28032742)

  • 1. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facile strategy to fabricate a pH-responsive mesoporous silica nanoparticle end-capped with amphiphilic peptides by self-assembly.
    Zhao F; Zhang C; Zhao C; Gao W; Fan X; Wu G
    Colloids Surf B Biointerfaces; 2019 Jul; 179():352-362. PubMed ID: 30991215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
    Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-Decorated Gold Nanoparticles as Functional Nano-Capping Agent of Mesoporous Silica Container for Targeting Drug Delivery.
    Chen G; Xie Y; Peltier R; Lei H; Wang P; Chen J; Hu Y; Wang F; Yao X; Sun H
    ACS Appl Mater Interfaces; 2016 May; 8(18):11204-9. PubMed ID: 27102225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A redox-responsive mesoporous silica nanoparticle with a therapeutic peptide shell for tumor targeting synergistic therapy.
    Xiao D; Hu JJ; Zhu JY; Wang SB; Zhuo RX; Zhang XZ
    Nanoscale; 2016 Sep; 8(37):16702-16709. PubMed ID: 27714082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery.
    Chen X; Sun H; Hu J; Han X; Liu H; Hu Y
    Colloids Surf B Biointerfaces; 2017 Apr; 152():77-84. PubMed ID: 28088015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
    Xiao D; Jia HZ; Ma N; Zhuo RX; Zhang XZ
    Nanoscale; 2015 Jun; 7(22):10071-7. PubMed ID: 25978679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
    Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
    Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
    Bhavsar DB; Patel V; Sawant KK
    Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.